ShreeOswal Seeds and Chemicals Limited - Laporan Laba Rugi (TTM)

ShreeOswal Seeds and Chemicals Limited
IN ˙ NSEI
Laporan Laba Rugi (TTM)

Laporan Laba Rugi ShreeOswal Seeds and Chemicals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,568 1,590 1,612 1,866 2,121 2,263 2,405 2,984 2,622 2,975 2,723 2,289 2,618 2,519 2,690 2,627 2,648 2,635 2,459 2,669
Change (%) 1.42 1.40 15.77 13.62 6.71 6.29 24.07 -12.12 13.43 -8.45 -15.94 14.36 -3.77 6.81 -2.37 0.81 -0.50 -6.67 8.54
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,453 1,477 1,501 1,741 1,980 2,118 2,256 2,792 2,467 2,797 2,552 2,148 2,455 2,405 2,625 2,630 2,658 2,552 2,311 2,367
Change (%) 1.65 1.62 15.95 13.76 6.97 6.51 23.76 -11.62 13.36 -8.77 -15.81 14.26 -2.03 9.17 0.19 1.05 -3.96 -9.45 2.40
% of Revenue 92.70 92.91 93.12 93.26 93.37 93.60 93.79 93.56 94.09 94.04 93.70 93.85 93.77 95.47 97.58 100.14 100.37 96.87 93.98 88.66
Gross Operating Profit 114 113 111 126 140 145 149 192 155 177 172 141 163 114 65 -4 -10 82 148 303
Change (%) -1.48 -1.50 13.30 11.74 3.13 3.04 28.68 -19.38 14.55 -3.27 -17.95 15.81 -30.01 -42.95 -105.48 171.20 -950.95 79.68 104.48
% of Revenue 7.30 7.09 6.88 6.74 6.63 6.40 6.21 6.44 5.91 5.96 6.30 6.15 6.23 4.53 2.42 -0.14 -0.37 3.13 6.02 11.34
SG&A 20 20 19 20 21 23 25 27 28 28 33 32 33 33 30 30 30 30 32 34
Change (%) -1.24 -1.25 4.01 3.85 9.04 8.29 7.68 5.08 1.11 15.60 -2.09 1.36 0.11 -8.84 1.14 0.33 0.10 6.71 6.08
% of Revenue 1.27 1.24 1.21 1.09 0.99 1.01 1.03 0.90 1.07 0.96 1.21 1.41 1.25 1.30 1.11 1.15 1.14 1.15 1.31 1.28
R&D
Change (%)
% of Revenue
OpEx 1,484 1,511 1,538 1,777 2,016 2,160 2,304 2,846 2,527 2,853 2,608 2,209 2,512 2,463 2,685 2,686 2,716 2,609 2,368 2,446
Change (%) 1.81 1.78 15.55 13.46 7.14 6.66 23.53 -11.18 12.90 -8.60 -15.29 13.72 -1.97 9.01 0.04 1.10 -3.93 -9.23 3.28
% of Revenue 94.67 95.03 95.38 95.20 95.07 95.45 95.79 95.37 96.38 95.93 95.76 96.51 95.98 97.78 99.81 102.27 102.56 99.02 96.30 91.64
Operating Income 84 79 74 90 105 103 101 138 95 121 115 80 105 56 5 -60 -68 26 91 223
Change (%) -5.41 -5.73 20.28 16.73 -1.61 -1.52 36.35 -31.40 27.68 -4.72 -30.81 31.89 -46.95 -90.64 -1,239.66 13.78 -138.14 251.84 145.44
% of Revenue 5.33 4.97 4.62 4.80 4.93 4.55 4.21 4.63 3.62 4.07 4.24 3.49 4.02 2.22 0.19 -2.27 -2.56 0.98 3.70 8.36
Interest Expense -22 -23 -24 -26 -28 -26 -25 -26 -27 -37 -36 -44 -48 -48 -57 -59 -52 -44 -41 -37
Change (%) 3.70 3.57 8.71 8.01 -6.07 -6.45 4.04 4.41 37.69 -2.30 21.61 9.80 0.56 17.48 4.74 -12.44 -15.09 -8.10 -9.98
% of Revenue -1.42 -1.45 -1.48 -1.39 -1.32 -1.16 -1.02 -0.86 -1.02 -1.24 -1.32 -1.91 -1.83 -1.91 -2.11 -2.26 -1.96 -1.67 -1.65 -1.37
Net Income 43 40 37 46 55 55 54 86 48 62 57 22 41 -9 -42 -89 -92 -5 35 135
Change (%) -7.56 -8.18 25.54 20.34 -0.72 -0.73 57.77 -43.64 28.57 -8.17 -62.28 90.37 -121.50 372.32 113.97 3.63 -94.19 -758.01 283.26
% of Revenue 2.74 2.50 2.26 2.46 2.60 2.42 2.26 2.87 1.84 2.09 2.10 0.94 1.57 -0.35 -1.55 -3.39 -3.48 -0.20 1.44 5.07

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista